Skip to main content
. 2013 Mar 18;4(1):35–48.

Table 2.

Association between variation in genes involved in tamoxifen metabolism and risk of contralateral breast cancer stratified by tamoxifen treatment status

Tamoxifen No Tamoxifen

un-corr un-corr
Gene SNP chr coordinate alleles MAF HWE1 RR2 95% CI P value RR2 95% CI P value
CYP2B6 rs2279342 19 46201967 A>T 0.09 0.85 1.4 0.8, 2.3 0.23 1.2 0.9, 1.6 0.24
CYP2B6 rs7250745 19 46195300 C>T 0.26 0.39 1.0 0.7, 1.5 0.96 1.1 0.9, 1.3 0.63
CYP2B6 rs2113103 19 46220507 G>A 0.15 0.87 0.8 0.5, 1.3 0.40 0.8 0.7, 1.1 0.16
CYP2B6 rs2306606 19 46208022 C>T 0.26 0.75 1.1 0.8, 1.6 0.54 1.0 0.8, 1.2 0.98
CYP2B6 rs1808682 19 46181288 G>A 0.23 0.48 0.9 0.6, 1.4 0.69 0.9 0.7, 1.1 0.35
CYP2B6 rs7255904 19 46220860 G>A 0.45 0.42 1.4 1.0, 1.9 0.07 1.1 0.9, 1.3 0.59
CYP2C9 rs1057910 (CYP2C9*3) 10 96731043 A>C 0.07 0.76 1.3 0.7, 2.4 0.37 1.1 0.8, 1.6 0.54
CYP2C9 rs1505 10 96740749 G>C 0.36 0.24 1.2 0.9, 1.6 0.40 0.9 0.8, 1.1 0.40
CYP2C9 rs12772884 10 96690620 T>A 0.44 0.16 0.9 0.7, 1.2 0.55 1.1 1.0, 1.4 0.15
CYP2C9 rs9332197 10 96730898 T>C 0.06 0.11 0.6 0.3, 1.1 0.10 1.1 0.7, 1.6 0.75
CYP2C19 NA 10 96522535 A>C 0.42 0.88 1.2 0.8, 1.6 0.38 1.0 0.8, 1.2 0.96
CYP2C19 NA 10 96524033 T>A 0.07 0.73 1.4 0.8, 2.6 0.23 1.1 0.8, 1.6 0.60
CYP2C19 rs6583954 10 96524253 A>G 0.15 0.37 1.1 0.7, 1.7 0.77 1.1 0.8, 1.4 0.64
CYP2C19 NA 10 96524465 C>A 0.07 0.73 1.4 0.8, 2.6 0.23 1.1 0.8, 1.6 0.54
CYP2C19 rs7916649 10 96524574 A>G 0.42 0.56 1.1 0.8, 1.5 0.48 1.0 0.8, 1.2 0.99
CYP2C19 rs17878459 10 96524912 C>G 0.03 0.32 1.7 0.7, 4.6 0.27 1.4 0.8, 2.2 0.23
CYP2C19 NA 10 96525114 G>A 0.15 0.42 1.1 0.7, 1.7 0.77 1.0 0.8, 1.3 0.76
CYP2C19 rs4388808 10 96526046 G>A 0.18 0.40 1.0 0.6, 1.5 0.86 1.3 1.0, 1.6 0.07
CYP2C19 NA 10 96526217 A>T 0.15 0.08 1.2 0.8, 2.0 0.36 1.1 0.8, 1.4 0.67
CYP2C19 rs7068577 10 96526698 A>G 0.20 0.22 0.9 0.6, 1.3 0.55 0.9 0.7, 1.1 0.43
CYP2C19 rs17878673 10 96529134 G>A 0.07 0.97 1.4 0.8, 2.6 0.23 1.1 0.8, 1.6 0.52
CYP2C19 rs4304697 10 96530879 A>G 0.07 0.66 1.5 0.8, 2.6 0.21 1.1 0.8, 1.6 0.51
CYP2C19 rs7088784 10 96531363 G>A 0.07 0.85 1.7 0.9, 2.9 0.09 1.2 0.8, 1.7 0.34
CYP2C19 rs4244285 (CYP2C19*2) 10 96531606 A>G 0.16 0.34 1.1 0.7, 1.7 0.76 1.1 0.8, 1.4 0.66
CYP2C19 rs12571421 10 96531972 G>A 0.16 0.19 1.1 0.7, 1.7 0.76 1.1 0.8, 1.4 0.66
CYP2C19 rs35390752 10 96533813 C>A 0.14 0.03 1.1 0.7, 1.8 0.73 1.0 0.8, 1.3 0.78
CYP2C19 NA 10 96534717 C>G 0.20 0.23 0.9 0.6, 1.3 0.55 0.9 0.7, 1.1 0.42
CYP2C19 NA 10 96534805 G>A 0.07 0.89 1.4 0.8, 2.5 0.27 1.1 0.8, 1.6 0.55
CYP2C19 NA 10 96534970 A>G 0.07 0.80 1.7 0.9, 3.0 0.08 1.2 0.8, 1.7 0.36
CYP2C19 NA 10 96535053 C>A 0.04 0.86 1.2 0.6, 2.2 0.65 1.2 0.8, 1.9 0.43
CYP2C19 NA 10 96535465 A>G 0.07 0.71 1.4 0.8, 2.5 0.30 1.1 0.8, 1.6 0.52
CYP2C19 NA 10 96535962 A>G 0.12 0.91 1.0 0.6, 1.6 0.83 0.7 0.6, 1.0 0.04
CYP2C19 NA 10 96536236 A>C 0.07 0.71 1.4 0.8, 2.5 0.29 1.1 0.8, 1.6 0.53
CYP2C19 NA 10 96536687 C>A 0.07 0.71 1.4 0.8, 2.5 0.29 1.1 0.8, 1.6 0.53
CYP2C19 rs12767583 10 96537453 A>G 0.16 0.34 1.1 0.7, 1.7 0.76 1.1 0.8, 1.3 0.69
CYP2C19 rs4494250 10 96553747 A>G 0.36 0.55 0.8 0.6, 1.2 0.31 0.9 0.7, 1.0 0.10
CYP2C19 NA 10 96555141 C>A 0.07 0.81 1.7 0.9, 2.9 0.09 1.2 0.8, 1.6 0.40
CYP2C19 NA 10 96556602 A>G 0.04 0.84 1.3 0.7, 2.4 0.50 1.2 0.8, 1.9 0.44
CYP2C19 NA 10 96556769 C>A 0.07 0.71 1.4 0.8, 2.5 0.29 1.1 0.8, 1.6 0.51
CYP2C19 rs12772672 10 96556879 G>A 0.16 0.39 1.1 0.7, 1.7 0.77 1.1 0.8, 1.3 0.72
CYP2C19 rs4641393 10 96557376 A>G 0.16 0.35 1.1 0.7, 1.7 0.74 1.1 0.8, 1.3 0.70
CYP2C19 rs1853205 10 96565059 C>G 0.16 0.32 1.1 0.7, 1.7 0.76 1.1 0.8, 1.3 0.69
CYP2C19 rs1322179 10 96565232 A>G 0.16 0.34 1.1 0.7, 1.7 0.76 1.1 0.8, 1.3 0.69
CYP2C19 NA 10 96565270 G>A 0.07 0.80 1.7 0.9, 3.0 0.08 1.2 0.8, 1.6 0.41
CYP2C19 rs10509678 10 96566180 G>A 0.07 0.71 1.4 0.8, 2.5 0.29 1.1 0.8, 1.6 0.53
CYP2C19 rs10786172 10 96571084 G>A 0.36 0.57 0.9 0.6, 1.2 0.34 0.9 0.7, 1.0 0.12
CYP2C19 NA 10 96572904 A>G 0.07 0.71 1.4 0.8, 2.5 0.29 1.1 0.8, 1.6 0.53
CYP2C19 NA 10 96587741 C>A 0.18 0.08 0.9 0.6, 1.4 0.58 0.9 0.7, 1.1 0.33
CYP2C19 NA 10 96588429 C>A 0.19 0.59 1.0 0.6, 1.5 0.82 1.2 1.0, 1.6 0.07
CYP2C19 NA 10 96591784 G>A 0.23 0.39 1.3 0.9, 1.8 0.19 1.1 0.9, 1.4 0.46
CYP2C19 NA 10 96591910 A>G 0.03 0.25 0.8 0.3, 2.2 0.59 0.7 0.4, 1.2 0.19
CYP2C19 rs28399513 10 96592388 A>T 0.16 0.33 1.1 0.7, 1.7 0.75 1.1 0.8, 1.4 0.66
CYP2C19 NA 10 96593081 A>T 0.07 0.60 1.4 0.8, 2.6 0.29 1.1 0.8, 1.6 0.46
CYP2C19 rs11592737 10 96593404 G>A 0.20 0.21 0.9 0.6, 1.3 0.46 0.9 0.7, 1.1 0.37
CYP2C19 NA 10 96593735 G>A 0.07 0.69 1.4 0.8, 2.5 0.29 1.1 0.8, 1.6 0.50
CYP2C19 NA 10 96595317 G>C 0.42 0.49 1.1 0.8, 1.5 0.55 1.0 0.8, 1.2 0.88
CYP2C19 rs1322181 10 96599054 A>G 0.42 0.69 1.1 0.8, 1.5 0.57 1.0 0.8, 1.2 0.96
CYP2C19 NA 10 96599463 A>G 0.04 0.83 1.2 0.6, 2.3 0.61 1.2 0.8, 1.9 0.44
CYP2C19 rs4917623 10 96599558 A>G 0.46 0.34 1.2 0.9, 1.6 0.27 1.0 0.9, 1.2 0.75
CYP2C19 rs17878382 10 96600621 G>A 0.07 0.71 1.4 0.8, 2.5 0.29 1.1 0.8, 1.6 0.52
CYP2C19 NA 10 96601618 G>A 0.20 0.17 0.9 0.6, 1.3 0.47 0.9 0.7, 1.1 0.29
CYP2C19 NA 10 96601824 A>G 0.42 0.43 1.1 0.8, 1.5 0.54 1.0 0.8, 1.2 0.98
CYP2C19 rs12268020 10 96602361 A>G 0.20 0.09 0.9 0.6, 1.3 0.47 0.9 0.7, 1.1 0.38
CYP2C19 rs35709381 10 96604715 A>C 0.16 0.34 1.1 0.7, 1.7 0.76 1.1 0.8, 1.3 0.69
CYP2C19 NA 10 96608493 G>A 0.04 0.86 1.2 0.6, 2.3 0.65 1.2 0.8, 1.9 0.44
CYP2C19 NA 10 96608992 A>G 0.07 0.68 1.4 0.8, 2.6 0.23 1.1 0.8, 1.6 0.50
CYP2C19 rs3862009 10 96609015 A>G 0.07 0.68 1.4 0.8, 2.5 0.29 1.1 0.8, 1.6 0.50
CYP2C19 rs733115 10 96609076 A>C 0.07 0.71 1.4 0.8, 2.6 0.23 1.1 0.8, 1.6 0.55
CYP2C19 NA 10 96609221 A>G 0.20 0.18 0.9 0.6, 1.3 0.51 0.9 0.7, 1.1 0.39
CYP2C19 NA 10 96610294 C>A 0.07 0.89 1.7 0.9, 2.9 0.09 1.2 0.8, 1.7 0.33
CYP2C19 NA 10 96611093 G>A 0.17 0.86 1.1 0.7, 1.7 0.85 1.0 0.8, 1.3 0.84
CYP2C19 rs12359148 10 96612303 G>A 0.03 0.18 1.5 0.6, 3.5 0.36 0.6 0.4, 1.1 0.10
CYP2D6 NA 22 40847933 G>C 0.44 0.59 1.1 0.8, 1.5 0.58 1.0 0.9, 1.2 0.78
CYP2D6 rs11090076 22 40844136 A>G 0.33 0.25 0.8 0.6, 1.1 0.16 0.9 0.8, 1.1 0.46
CYP2D6 rs28371717 22 40854254 C>A 0.01 0.76 0.0 2.1 0.9, 5.0 0.08
CYP2D6 rs28371725 (CYP2D6*41) 22 40853749 G>A 0.08 0.003 0.8 0.5, 1.5 0.50 1.1 0.8, 1.6 0.64
CYP2D6 rs5751221 22 40846312 G>A 0.23 0.61 1.2 0.8, 1.7 0.45 1.1 0.9, 1.3 0.66
CYP2D6 rs5758589 22 40848326 G>A 0.44 0.72 1.1 0.8, 1.5 0.52 1.0 0.9, 1.2 0.72
CYP2D6 rs6002623 22 40843707 G>A 0.33 0.25 0.8 0.6, 1.1 0.16 0.9 0.8, 1.1 0.46
CYP2D6 rs764481 22 40848370 G>A 0.33 0.23 0.8 0.6, 1.1 0.16 0.9 0.8, 1.1 0.46
CYP2D6 rs3892097 (CYP2D6*4) 22 40854891 G>A 0.22 0.01 1.2 0.8, 1.7 0.31 1.1 0.9, 1.3 0.63
CYP3A4 rs2242480 7 99199402 C>T 0.11 0.18 0.8 0.4, 1.3 0.32 0.9 0.7, 1.2 0.48
CYP3A4 rs11773597 7 99220387 G>C 0.07 0.54 1.2 0.7, 2.3 0.54 1.1 0.8, 1.6 0.57
CYP3A4 rs1851426 7 99220872 G>A 0.04 0.56 0.8 0.4, 1.8 0.61 1.1 0.7, 1.7 0.78
CYP3A4 rs2246709 7 99203655 A>G 0.27 0.32 0.9 0.6, 1.3 0.58 1.0 0.8, 1.2 0.87
CYP3A4 rs2404955 7 99191215 G>A 0.1 0.02 0.8 0.5, 1.5 0.51 0.9 0.6, 1.2 0.42
CYP3A4 rs2740574 7 99220032 A>G 0.04 0.56 0.8 0.4, 1.8 0.61 1.1 0.7, 1.7 0.78
CYP3A4 rs3735451 7 99193911 A>G 0.12 0.6 0.9 0.6, 1.5 0.72 1.0 0.7, 1.3 0.93
CYP3A5 rs776746 (CYP3A5*3) 7 99108475 G>A 0.07 0.13 0.8 0.4, 1.6 0.49 0.7 0.5, 1.0 0.05
CYP3A5 rs10242455 7 99078115 A>G 0.07 0.23 0.7 0.4, 1.4 0.38 0.7 0.5, 1.0 0.04
CYP3A5 rs1419745 7 99098028 A>G 0.03 0.53 1.0 0.4, 2.7 0.98 0.5 0.3, 0.9 0.02
CYP3A5 rs15524 7 99083850 A>G 0.08 0.15 0.8 0.4, 1.6 0.56 0.7 0.5, 1.0 0.04
CYP3A5 rs17161780 7 99076077 G>A 0.03 0.43 0.9 0.3, 2.7 0.89 0.5 0.3, 0.9 0.02
CYP3A5 rs17161783 7 99076278 A>G 0.03 0.43 0.9 0.3, 2.7 0.89 0.5 0.3, 0.9 0.02
CYP3A5 rs28365067 7 99110246 G>A 0.06 0.36 0.6 0.3, 1.3 0.23 1.0 0.7, 1.5 0.94
CYP3A5 rs28365083 7 99088172 C>A 0.01 0.001 1.3 0.3, 5.0 0.75 2.0 0.9, 4.7 0.10
CYP3A5 rs28365094 7 99088411 A>G 0.1 0.97 1.8 1.1, 3.1 0.02 1.2 0.9, 1.6 0.24
CYP3A5 rs28371764 7 99115529 G>A 0.04 0.49 0.8 0.4, 1.9 0.63 1.0 0.6, 1.6 0.87
CYP3A5 rs4646446 7 99113019 G>A 0.03 0.43 0.9 0.3, 2.7 0.89 0.5 0.3, 0.9 0.02
CYP3A5 rs4646447 7 99106326 G>A 0.03 0.43 0.9 0.3, 2.7 0.88 0.5 0.3, 1.0 0.04
CYP3A5 rs4646450 7 99104254 G>A 0.17 0.26 0.9 0.6, 1.4 0.75 1.0 0.8, 1.2 0.75
CYP3A5 rs4646456 7 99083211 A>G 0.03 0.43 0.9 0.3, 2.7 0.88 0.5 0.3, 0.9 0.02
CYP3A5 rs4646457 7 99083016 A>C 0.08 0.24 0.8 0.4, 1.5 0.49 0.7 0.5, 1.0 0.04
CYP3A5 rs4646458 7 99082949 A>C 0.03 0.53 1.0 0.4, 2.7 0.98 0.5 0.3, 0.9 0.02
CYP3A5 rs6956305 7 99079246 A>G 0.04 0.09 0.7 0.3, 1.7 0.42 0.9 0.6, 1.3 0.49
SULT1A1 rs2411453 16 28539522 C>A 0.38 0.45 1.1 0.8, 1.5 0.74 0.8 0.7, 1.0 0.07
SULT1A1 rs1968752 16 28539086 C>A 0.35 0.15 1.1 0.8, 1.5 0.77 0.9 0.7, 1.0 0.11
SULT1A1 rs2077412 16 28528812 G>A 0.3 0.01 1.0 0.7, 1.4 0.85 1.0 0.9, 1.3 0.74
UGT2B15 rs1377872 4 69588127 G>A 0.13 0.83 1.2 0.8, 1.9 0.42 1.3 1.0, 1.7 0.04
UGT2B15 rs3100 4 69547273 A>G 0.36 0.66 0.7 0.5, 0.9 0.02 0.9 0.7, 1.0 0.09
UGT2B15 rs4148271 4 69547255 T>A 0.02 0.57 0.8 0.2, 2.9 0.76 1.5 0.7, 3.4 0.29
UGT2B15 rs7696472 4 69572785 G>A 0.46 0.31 1.0 0.8, 1.4 0.82 1.1 0.9, 1.3 0.38

Abbreviations: SNP=single nucleotide polymorphism; CHR=chromosome; MAF=minor allele frequency; HWE=Hardy-Weinberg equilibrium; RR=relative risk; 95% CI=95% confidence interval; NA=Not applicable.

1

HWE in UBC controls, p<0.001.

2

Per allele RR (log-additive model) adjusting for age at diagnosis and the counter-matching offset term.